AUPH (Aurinia Pharmaceuticals) Technical Analysis

AUPH Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
AUPH
AUPH

Aurinia Pharmaceuticals

$16.25-4.07%
Today's High$16.99
Today's Low$16.19
Today's Open$16.98
Yesterday's Close$16.94

AUPH (Aurinia Pharmaceuticals) Technical Analysis Overview

AI CreationAs of July 1, 2026, Aurinia Pharmaceuticals (AUPH) is showing bullish momentum within a consolidation structure. The MACD Level at 0.4659 confirms a Buy signal with golden cross formation indicating sustained momentum expansion, while the RSI(14) at 57.0208 positions the stock in a neutral-to-strong zone reflecting balanced bullish conviction. The moving average system displays pronounced bullish alignment, with EMA10 at 17.0603 trading above EMA20 at 16.6701 and SMA200 at 14.7638, establishing a clear uptrend structure across multiple timeframes. All major moving averages remain arrayed in bullish sequence, confirming short-term directional persistence, though the one-day change of 2.32 percent signals consolidation within the broader uptrend.

Oscillators

Strong Sell
Strong Buy
Sell
2
Sell
9
Neutral
0
Buy

Summary

Strong Sell
Strong Buy
Neutral
9
Sell
10
Neutral
7
Buy

Moving Averages

Strong Sell
Strong Buy
Neutral
7
Sell
1
Neutral
7
Buy

AUPH (Aurinia Pharmaceuticals) Live Candlestick Chart

AUPH (Aurinia Pharmaceuticals) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)21241077131
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)35.443.248.060.4
MACD (12,26)Death CrossGolden CrossGolden CrossGolden Cross

AUPH (Aurinia Pharmaceuticals) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
48.0088Neutral
Stochastic %K (14, 3, 3)
31.7504Neutral
Commodity Channel Index (CCI) (20)
-3.9745Neutral
Average Directional Index (ADX) (14)
25.9225Neutral
Awesome Oscillator (AO)
1.0604Neutral
Momentum Indicator (10)
0.0305Sell
MACD Level (12, 26)
0.3612Sell
Stochastic RSI Fast (3, 3, 14, 14)
9.568Neutral
Williams Percent Range (%R) (14)
-79.3519Neutral
Bull Bear Power (BBP)
-0.2737Neutral
Ultimate Oscillator (UO) (7, 14, 28)
42.0533Neutral

Moving Averages

NameValueOperation
EMA (10)
16.8825Sell
SMA (10)
17.142Sell
EMA (20)
16.6125Sell
SMA (20)
16.5145Sell
EMA (30)
16.394Sell
SMA (30)
16.1507Buy
EMA (50)
16.0963Buy
SMA (50)
16.0038Buy
EMA (100)
15.5719Buy
SMA (100)
15.392Buy
EMA (200)
14.4599Buy
SMA (200)
14.7804Buy
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
17.1075Neutral
Volume-Weighted Moving Average (VWMA) (20)
16.9096Sell
Hull Moving Average (HMA) (9)
16.5518Sell

AUPH (Aurinia Pharmaceuticals) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R325.631721.346718.148423.4675-
R221.346719.709817.755621.3588-
R119.158318.698517.362819.182520.2525
Pivot P17.061717.061717.061717.073817.6088
S114.873315.424816.577214.897515.9675
S212.776714.413516.184412.7888-
S38.491712.776715.791610.6125-

AUPH (Aurinia Pharmaceuticals) Market Sentiment Index

Analyst Rating17
Options Put/Call Ratio+16.54%
Implied Volatility (IV)14.0059

AUPH (Aurinia Pharmaceuticals) Deep Technical Analysis

As of July 1, 2026, AUPH is exhibiting a bullish technical structure. The **AUPH technical analysis** framework reveals a MACD Level at 0.4659 confirming a Buy signal with golden cross formation, indicating sustained momentum expansion, while the RSI(14) at 57.0208 positions the stock in a neutral-to-strong zone that reflects balanced bullish and bearish forces with room for directional development. The Average Directional Index (14) stands at 27.7115 with a Neutral signal, indicating moderately strong trend persistence that reflects meaningful directional conviction without extreme trend dominance. This moderate-to-strong ADX reading, combined with the Commodity Channel Index showing a Neutral signal at 52.4371 and Momentum(10) at 1.175 signaling Buy, creates a framework where primary trend indicators remain supportive of the directional bias. The moving average system reinforces the bullish structure through consistent alignment. EMA10 at 17.0603 trades above both EMA20 at 16.6701 and EMA50 at 16.098, confirming short-term uptrend persistence, while SMA200 at 14.7638 sits well below current price action serving as a robust longer-term support floor that validates the broader uptrend. The AUPH market analysis reveals that all major moving averages are arrayed in bullish sequence, with shorter-period averages above longer-period ones, establishing a structurally sound uptrend foundation. In terms of key levels, Fibonacci retracement points provide tactical reference zones. Resistance targets are clustered at R1 (16.0654), R2 (16.5121), and R3 (17.2351), while the current price at 17.14 trades near the R3 level, suggesting the stock remains in extended technical territory. Support levels are positioned at S1 (14.6194), S2 (14.1727), and S3 (13.4497), with the one-day range low of 16.85 providing near-term floor support. The near-term AUPH price forecast remains shaped by the tension between moderately strong trend persistence and the stock's proximity to upper resistance levels. On the market breadth front, the option put-call ratio stands at 16.54, indicating moderately elevated hedging activity and a defensive positioning bias despite the bullish price structure. The analyst rating of 17 reflects overall positive sentiment from the research community, suggesting fundamental support for the bullish technical posture. The implied volatility reading of 14.0059 indicates relatively low expected price swings, which may constrain the magnitude of moves but does not alter the directional bias; the AUPH price prediction reflects a structural uptrend with contained volatility expectations.

FAQ

What is the current technical rating for AUPH?

x
On the 4H timeframe, the aggregate technical rating for AUPH is Neutral. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for AUPH?

x

What are the current RSI and MACD signals for AUPH?

x

How often is the AUPH technical analysis data updated?

x

Continue Exploring AUPH (Aurinia Pharmaceuticals)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.